Pierre Morel

Treatment of Acute Promyelocytic Leukemia: A Report of 70 Cases

Pierre Fenaux, Jean Paul Pollet, Lieve Vandenbossche-simon et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1991 · 71 citations

Hematological Malignancy, Ara C, Oncology +9

Report of consensus Panel 4 from the 11th International Workshop on Waldenstrom's macroglobulinemia on diagnostic and response criteria

Steven P. Treon, Alessandra Tedeschi, Jesús F. San Miguel et al. · Seminars in Hematology · 2023 · 55 citations

Medicine, Consensus Panel 4, Immunology +7

Th17 and CD24hiCD27+ regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis

Sarah Salomon, Caroline Guignant, Pierre Morel et al. · Arthritis Research & Therapy · 2017 · 48 citations · Full text

Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections

Giorgio Zanetti, Stephan Jürgen Harbarth, Andrej Trampuž et al. · International Journal of Antimicrobial Agents · 1999 · 31 citations

Antibiotics, Medicine, Sepsis +3

Bendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.

Jithma P. Abeykoon, Shaji Kumar, Jorge J. Castillo et al. · Journal of Clinical Oncology · 2022 · 14 citations

Immunodeficiencies, Immunology, Active Tn Wm +21